These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 26205471)

  • 1. Expression of proteins involved in DNA damage response in familial and sporadic breast cancer patients.
    Partipilo G; Simone G; Scattone A; Scarpi E; Azzariti A; Mangia A
    Int J Cancer; 2016 Jan; 138(1):110-20. PubMed ID: 26205471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological and clinical significance of PARP1 protein expression in breast cancer.
    Green AR; Caracappa D; Benhasouna AA; Alshareeda A; Nolan CC; Macmillan RD; Madhusudan S; Ellis IO; Rakha EA
    Breast Cancer Res Treat; 2015 Jan; 149(2):353-62. PubMed ID: 25528020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear PARP1 expression and its prognostic significance in breast cancer patients.
    Mazzotta A; Partipilo G; De Summa S; Giotta F; Simone G; Mangia A
    Tumour Biol; 2016 May; 37(5):6143-53. PubMed ID: 26614429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA damage response markers are differentially expressed in BRCA-mutated breast cancers.
    Aleskandarany M; Caracappa D; Nolan CC; Macmillan RD; Ellis IO; Rakha EA; Green AR
    Breast Cancer Res Treat; 2015 Feb; 150(1):81-90. PubMed ID: 25690937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NHERF1 together with PARP1 and BRCA1 expression as a new potential biomarker to stratify breast cancer patients.
    Mangia A; Scarpi E; Partipilo G; Schirosi L; Opinto G; Giotta F; Simone G
    Oncotarget; 2017 Sep; 8(39):65730-65742. PubMed ID: 29029467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1 protein expression and its correlation with ER/PR status in sporadic and familial breast cancer in Eastern Indian patients--a hospital based study.
    Ashraf M; Jha JK; Mukherjee N; Panda CK; Nayak S; Jadhav TS; Dikshit N; Nath NC; Chakraborty J; Biswas J
    J Indian Med Assoc; 2011 Dec; 109(12):873-8. PubMed ID: 23469566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in poly (ADP-ribose) polymerase-1 (PARP1) promoter and 3' untranslated region and their association with PARP1 expression in breast cancer patients.
    Zhai L; Li S; Li H; Zheng Y; Lang R; Fan Y; Gu F; Guo X; Zhang X; Fu L
    Int J Clin Exp Pathol; 2015; 8(6):7059-71. PubMed ID: 26261599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer.
    Aloraifi F; Alshehhi M; McDevitt T; Cody N; Meany M; O'Doherty A; Quinn CM; Green AJ; Bracken A; Geraghty JG
    Eur J Surg Oncol; 2015 May; 41(5):641-6. PubMed ID: 25736863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(adenosine diphosphate-ribose) polymerase expression in BRCA-proficient ovarian high-grade serous carcinoma; association with patient survival.
    Gan A; Green AR; Nolan CC; Martin S; Deen S
    Hum Pathol; 2013 Aug; 44(8):1638-47. PubMed ID: 23574784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher cytoplasmic and nuclear poly(ADP-ribose) polymerase expression in familial than in sporadic breast cancer.
    Klauke ML; Hoogerbrugge N; Budczies J; Bult P; Prinzler J; Radke C; van Krieken JH; Dietel M; Denkert C; Müller BM
    Virchows Arch; 2012 Oct; 461(4):425-31. PubMed ID: 22968923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial breast cancers without mutations in BRCA1 or BRCA2 have low cyclin E and high cyclin D1 in contrast to cancers in BRCA mutation carriers.
    Aaltonen K; Blomqvist C; Amini RM; Eerola H; Aittomäki K; Heikkilä P; Nevanlinna H
    Clin Cancer Res; 2008 Apr; 14(7):1976-83. PubMed ID: 18381935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune response to PARP and BRCA1/BRCA2 in cancer.
    Zhu Q; Han SX; Zhou CY; Cai MJ; Dai LP; Zhang JY
    Oncotarget; 2015 May; 6(13):11575-84. PubMed ID: 25865228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short telomeres are frequent in hereditary breast tumors and are associated with high tumor grade.
    Martinez-Delgado B; Gallardo M; Tanic M; Yanowsky K; Inglada-Perez L; Barroso A; Rodriguez-Pinilla M; Cañamero M; Blasco MA; Benitez J
    Breast Cancer Res Treat; 2013 Sep; 141(2):231-42. PubMed ID: 24036693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
    Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
    Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoprofile from tissue microarrays to stratify familial breast cancer patients.
    Schirosi L; De Summa S; Tommasi S; Paradiso A; Sambiasi D; Popescu O; Simone G; Mangia A
    Oncotarget; 2015 Sep; 6(29):27865-79. PubMed ID: 26312763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARP1 and phospho-p65 protein expression is increased in human HER2-positive breast cancers.
    Stanley J; Klepczyk L; Keene K; Wei S; Li Y; Forero A; Grizzle W; Wielgos M; Brazelton J; LoBuglio AF; Yang ES
    Breast Cancer Res Treat; 2015 Apr; 150(3):569-79. PubMed ID: 25833211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human epidermal growth factor receptor 2, Na+/H+ exchanger regulatory factor 1, and breast cancer susceptibility gene-1 as new biomarkers for familial breast cancers.
    Mangia A; Malfettone A; Saponaro C; Tommasi S; Simone G; Paradiso A
    Hum Pathol; 2011 Nov; 42(11):1589-95. PubMed ID: 21496870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-2 is a highly significant prognostic marker of hormone-receptor-positive, human epidermal growth factor receptor-2-negative breast cancer.
    Seong MK; Lee JY; Byeon J; Sohn YJ; Seol H; Lee JK; Kim EK; Kim HA; Noh WC
    Breast Cancer Res Treat; 2015 Feb; 150(1):141-8. PubMed ID: 25682076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of BRCA1 protein in invasive ductal carcinoma of the breast.
    Burkadze G; Khardzeishvili O; Gudadze M; Tsikhiseli G; Turashvili G
    Georgian Med News; 2010; (184-185):51-60. PubMed ID: 20834076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the forkhead box transcription factor FOXP1 is associated with oestrogen receptor alpha, oestrogen receptor beta and improved survival in familial breast cancers.
    Rayoo M; Yan M; Takano EA; Bates GJ; Brown PJ; Banham AH; Fox SB
    J Clin Pathol; 2009 Oct; 62(10):896-902. PubMed ID: 19622517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.